Sebastien Wälchli invited speaker at the 25th Porto Cancer Meeting

Sebastien Wälchli will present the depatment of Cellular Therapy at the 25th Porto Cancer Meeeting.

More details here and here

 

We will be at AACR 2018

 

 

Pierre Dillard will attend the 2018 meeting of the American Association for Cncer Research (AACR). He will present our recent work on universal killer, make sure to have a look !

 

New publication from our group in Cancer Immunology

Human c-SRC kinase (CSK) overexpression makes T cells dummy

Patient safety upon immunotherapy treatment is a challenge that still need to be adressed.

In this publication we report how by affecting c-SRC kinase we can make T-cells "dummy": effector cells are still able to recognize and bind to the target but unable to carry on with their activation. This mechanism could potentially open the way for a safe-lock system permitting to reduce off-target toxicity.

Image from: Ellen Tenstad/Science Shaped

 

T lymphocytes killing melanoma cells....

 

Nadia Mensali won the presentation prize at the annual NSI meeting!

 

Nadia Mensali was awarded with the presentation prize for her talk on the Universal Killer! See below to learn more

 

We will be at SITC 2017 !

 

Nadia Mensali and Pierre Dillard will attend the 2017 meeting of the Society for ImmunoTherapy of Cancer (SITC). They will present our recent work on universal killer and CD4 Adoptive cell therapy, make sure to have a look !

 

We published a new paper in Scientific Reports !

Our team published a new paper about using TCR in CAR design, make sure to have a look here !

 

Our research team is well represented in the new Olo Cancer Cluster presentation book!

The new Oslo Cancer Cluster presentation book is out!

Have a look here: 

OCC presentation

 

We will be at PIVAC 2017 at the end of September

 Marit Renee Myhre has been selected to give a talk at  the 17th International Conference on Progress in  Vaccination Against Cancer (PIVAC 2017) in Loutraki,  Corinth, Greece

 She will present our latest work on our new CD4-based therapy, make sure to have a look at the abstract if you want  to learn more !

 

 

New publication: therapeutic T-cell receptors in healthy donor blood, is safety predictable?

Our team has published a new paper in Translational Cancer Research:


New publication in our team: therapeutic T-cell receptors in healthy donor blood, is safety predictable? by Hakan Köksal and Sébastien Wälchli.
They are commenting a paper published in 2017 in Blood by Jahn et al. that presents a novel TCR-based therapy trageting intracellular transcription factor. Make sure to have a look at both papers!

 
Page visits: 329